Deciphering the Late Biosynthetic Steps of Antimalarial Compound FR-900098
- 28 January 2010
- journal article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 17 (1), 57-64
- https://doi.org/10.1016/j.chembiol.2009.12.009
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cloning, Expression, and Biochemical Characterization of Streptomyces rubellomurinus Genes Required for Biosynthesis of Antimalarial Compound FR900098Cell Chemical Biology, 2008
- Kinetic Analysis of Escherichia coli 2-C-Methyl-d-erythritol-4-phosphate Cytidyltransferase, Wild Type and Mutants, Reveals Roles of Active Site Amino AcidsBiochemistry, 2004
- Fosmidomycin‐Clindamycin forPlasmodium falciparumInfections in African ChildrenThe Journal of Infectious Diseases, 2004
- New Antimalarial DrugsAngewandte Chemie-International Edition, 2003
- Medical need, scientific opportunity and the drive for antimalarial drugsNature, 2002
- The role of lateral gene transfer in the evolution of isoprenoid biosynthesis pathwaysMolecular Microbiology, 2000
- Studies on phosphonic acid antibiotics. IV. Synthesis and antibacterial activity of analogs of 3-(N-acetyl-N-hydroxyamino)-propylphosphonic acid (FR-900098).CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289.The Journal of Antibiotics, 1980
- Studies on new phosphonic acid antibiotics. I. FR-900098, isolation and characterization.The Journal of Antibiotics, 1980
- Biochemistry of Polyisoprenoid BiosynthesisAnnual Review of Biochemistry, 1976